| Trial ID: | L6565 |
| Source ID: | NCT00613288
|
| Associated Drug: |
Testosterone (Testogel), Gnrh Analog (Leuprorelide) And Placebo
|
| Title: |
Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypogonadism
|
| Interventions: |
DRUG: Testosterone (Testogel), GnRH analog (Leuprorelide) and Placebo
|
| Outcome Measures: |
Primary: Testosterone influence on Insulin Sensitivity, Lipolysis and protein metabolism, 4-6 month pr patient | Secondary: Testosterone influence on Body composition by DEXA scan, Energy expenditure by indirect Calorimetry and VO2 max test, 4-6 month pr patient
|
| Sponsor/Collaborators: |
Sponsor: University of Aarhus
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2007-09
|
| Completion Date: |
2009-09
|
| Results First Posted: |
|
| Last Update Posted: |
2009-10-22
|
| Locations: |
Medical department M and Investigational Laboratories, Aarhus C, Jutland, 8000, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00613288
|
